Adult Congenital Heart Disease Guideline
The 2018 Adult Congenital Heart Disease (ACHD) guideline is a full revision of the "2008 ACC/AHA Guidelines for the Management of Adults with Congenital Heart Disease", which was the first U.S. guideline to be published on the topic. ACHD prevalence is growing due to the success of pediatric cardiology and congenital cardiac surgery in diagnosing and treating congenital heart defects in children. Improved survival to adulthood is most striking for those with the most severe disease, with survival to age 18 now expected for 90% of children diagnosed with severe congenital heart disease (CHD). This guideline is not intended to apply to children (<18 years of age) with CHD or adults with acquired valvular heart disease, heart failure, or other cardiovascular diseases.
Central Illustration: 2018 AHA/ACC Guideline for the Management of Adults with Congenital Heart Disease
- Shunt Lesions, Atrial Septal Defect, Ventricular Septal Defect, Coarctation of the Aorta, Tetralogy of Fallot, Transposition of the Great Arteries, Coronary Anomalies, Ebstein Anomaly, Congenital Valvular Aortic Stenosis
TOOLS & TIPS
The American College of Cardiology (ACC)—along with collaborative societies—create Clinical Practice Guidelines, which become ACC policy at the time of publication. All Clinical Practice Guidelines undergo rigorous peer review that is independent of the Editors/editorial processes of the Journal of the American College of Cardiology (JACC). JACC Editors receive no compensation from the publication of the guidelines nor other ACC clinical/policy documents. For more information on guideline processes, click here: About Guidelines and Clinical Documents